Occupational exposures cause 10-15% of new-onset asthma in adults, and that represents a considerable health and economic burden. Exposure to many causative agents is now well controlled but workplace practices are constantly evolving and new hazards being introduced. Overall, there is no good evidence that the incidence of occupational asthma is decreasing. Evidence-based guidelines such as those published by the British Occupational Health research Foundation and Standards of Care documents should help raise awareness of the problem and improve management. Key targets include the control of occupational exposures, a high index of suspicion in any adult with new onset asthma, and early detailed investigation.
Introduction
Occupational asthma is a common disease and one that is at least in theory entirely preventable. It has been recognized since antiquity and has been subject to scientific scrutiny and legislative control for several decades. Despite that, there is no good evidence that it is becoming less common. For affected individuals, the costs to their health and livelihood can be considerable, and the economic burden to society is substantial. Its proper control presents a considerable challenge.
Recently developed guidelines such as those of the British Occupational Hygiene Research Foundation (BOHRF) have drawn attention to the problems and should help standardize management. 1 This review draws particularly on the BOHRF guidelines and discusses a number of the key evidence statements.
Prevalence and causes
Asthma affects up to 20% of the population. 2 It is the commonest respiratory disease among young adults, and approximately half develop their disease during their working years 3 when they are potentially exposed to harmful occupational environments. Epidemiological studies indicate that 10-15% of asthma in adults can be attributed to work. 1, 4, 5 
Definitions and terminology
Occupational asthma is asthma that is caused by workplace exposures to airborne dusts, gases, vapours or fumes. 4 Usually, the asthma develops de novo but long-standing asthmatics are not protected and can present with worsening of their pre-existing disease. Occupational asthma bears many of the features of an immunologically mediated disease: specific immunoglobulin E (IgE) antibodies can often be detected; there is a characteristic latent interval of asymptomatic exposure during which sensitization can be observed to develop; and affected individuals become hypersensitive to low-level exposures that were previously well tolerated.
The causative agents are categorized as high molecular weight (>1 kDa) allergens such as flour or laboratory animal proteins, or low molecular weight (<1 kDa) chemicals such as isocyanates. 6 The former stimulate an immune response directly and are usually associated with specific IgE antibodies. Low molecular weight agents are believed to act as haptens and form immunogenic complexes with airway proteins. With a few exceptions such as platinum salts, 7 specific antibodies to low molecular weight chemicals are more difficult to detect though they are still likely to be involved in the pathogenesis of the disease. 8, 9 Individuals with non-occupational asthma often experience symptoms at work triggered by exertion, extremes of temperature or irritant dusts or fumes. That is known as work-exacerbated asthma. The term work-related asthma can be used to encompass both work-exacerbated and occupational asthma. There can be considerable practical difficulties distinguishing the two conditions as occupational asthma is often caused by exposures that are also irritants. Workexacerbated asthma is a cause of significant morbidity 10 and many affected individuals leave their work. The prognosis when they do so is better than with occupational asthma 11 and the condition is not considered in detail in this review.
Occupational asthma occasionally develops within hours of a massive exposure to an irritant substance such as chlorine gas. This time-course makes immune sensitization unlikely and the term acute irritant asthma or reactive airways dysfunction syndrome is used. 12 Intermittent, more modest exposures to irritants such as chlorine and sulphur dioxide (SO 2 ) can induce asthma, for example, with repeated gassings in the paper pulp industry. 13, 14 It is possible that chronic low level exposures to irritants may have the same effect but whether and how often that occurs is debated. 15 An analogy can be drawn with cigarette smoke which is an irritant to the airways and might be associated with asthma in adults but it is clearly not a common cause. 16 Occasionally, the term occupational asthma with latency is used to distinguish the more common form from acute irritant asthma.
Prevalence and trends
There are a number of national and regional reporting schemes such as the UK Health and Occupation Reporting Network (THOR) that identify cases of occupational asthma. 17 Several hundred causative agents or environments are recognized but a relatively small number account for more than half of all cases (Table 1) . Often exposures are associated with specific jobs, and the occupations most commonly implicated include paint sprayers, bakers and pastry makers, nurses, chemical workers, animal handlers, welders, food processing workers and timber workers. 1 THOR currently estimates approximately 600 cases per year, equivalent to approximately 20 cases per million workers or 2-6% of adult onset asthma. 17 However, reporting schemes are likely to underestimate occupational asthma prevalence by up to 50% as individuals can be managed without coming to the attention of a reporting specialist. 1, 18, 19 The morbidity associated with occupational asthma can also be estimated from population-based epidemiological studies such as the European Community Respiratory Health Survey (ECRHS). 20 The prevalence of asthma in different occupational groups is estimated taking no account of the work-relatedness of individuals' symptoms. The proportion of asthma attributable to work can then be calculated if some working groups are found to have more asthma than others. The first ECRHS survey found that 10% of asthma in young adults could be explained by the increased risk in the nine occupational groups with the highest odds ratios for asthma. 21 A follow-up study identified a 1.7-fold risk of new onset asthma over the course of 1 year in those employed in high-risk occupations, equivalent to a 14% contribution from occupational exposures. 22 These and other studies suggest that 9-15% of asthma in adults of working age is caused by their work. 1, 22 A further sizeable proportion of asthmatics have symptoms that are exacerbated by occupational exposures, 10 and overall it is estimated that up to 25% of adult asthmatics are in some way affected by their work. 4 Reporting schemes and epidemiological surveys both identify groups such as bakers and spraypainters as at increased risk of occupational asthma. 5, 17 There are, however, some striking differences. Cleaners are not commonly identified in clinical practice or by reporting schemes, but epidemiological studies consistently identify them as at high risk with odds ratios for asthma of about 2.0. 21, 23, 24, 25 They form a sizeable though poorly regulated part of the working population 25 and their health is potentially a major public health issue. The mechanism of their asthma is also of some interest. The relative rarity of the clinical diagnosis of occupational asthma suggests that it develops gradually with little short-term change in lung function that might allow the association with exposures to be recognized. It might be an example of low dose irritant asthma caused by repeated exposure to chlorine in bleaches or some other agent.
There is no good evidence that the incidence of occupational asthma has decreased in recent years. 1 This is likely to be the result of several competing trends as some individual causes have clearly been controlled 17, 26, 27 but others have emerged or become more common. 28 New materials and techniques are continually being introduced into workplaces, and the workforce may be becoming more susceptible because of an increased prevalence of atopy. 2 The break-up of large industries into smaller businesses can lead to poorer control of exposures, as might the shift of manufacturing industry to less industrialized countries.
Predisposing factors
Instances are recognized in which half or more of exposed workers have developed occupational asthma, and it is likely that almost everyone is at risk if sufficiently exposed. 29 Typically, only a small minority is affected and individual susceptibility is of considerable importance. Age and sex have no substantial influence but smoking and atopy do. There are other likely genetic markers, particularly alleles of major histocompatibility (MHC) complex genes that are involved in antigen recognition 1, 30, 31 but the study of these is still in its infancy. There are legal and ethical issues that would be raised by selecting workers on the basis of a genetic characteristic but preemployment genetic screening is currently too poorly discriminating to be of any practical value. 1 Any attempt at selecting non-susceptible employees is likely only to distract from the more important task of minimizing the risk for all.
Exposures
Exposure to a causative environment is clearly necessary for the development of occupational asthma and there is good evidence that the risk is increased by heavier exposures. 6, 32, 33 Removing or reducing the levels of exposure is the most effective step any employer can take to decrease the risk. 33, 34 This should follow an established hierarchy of measures 35 : substituting for a less hazardous material; changing to a form that is less likely to be inhaled; enclosing the process; providing adequate exhaust ventilation and providing personal protective equipment.
The management of latex asthma provides a useful illustration of the emergence and the subsequent control of a problem. Natural latex rubber contains more than 13 Hev allergens. 36 These leach into the powder of powdered gloves during storage and become airborne as the glove is removed from the packaging. Asthma from this source became common in healthcare workers in the early 1990s as infection control measures became more stringent and the use of rubber gloves increased. Of exposed individuals, 5% or more were affected. [37] [38] [39] [40] Recognition of the problem, reduction in the latex content of the rubber, removal of the powder, a switch to non-latex gloves and education programmes together led to a substantial decrease in asthma rates. In Germany, the number of registered cases fell from a peak of approximately 115 cases in 1997 to fewer than 20 cases in 2001 ( Figure 1 ). 27 Similar effects were noted with a control programme in Ontario hospitals. 41 While it is clear that reducing exposures decreases the incidence of occupational asthma, 1 little is known of the precise exposure-response relationship for most agents and safe exposure limits are difficult to establish. Workplace exposures can be difficult to quantify and 6 and safe limits can be very low; lower even than the limit of chemical detection. 42 Patterns of exposure might also be important with intermittent high levels being more likely to stimulate an immune response and asthma than more continuous lower level exposures. 6, 43 Groups such as maintenance workers with occasional peaks of exposure can therefore be particularly at risk. 44 The use of personal respiratory protective equipment reduces the incidence of, but does not completely prevent occupational asthma. 1 That probably reflects the practical difficulties in eliminating exposures by that means. Protective equipment is often provided only after an individual develops asthma and has become highly sensitized even to minimal exposures. Skin exposure might be an important route of sensitization with some agents such as isocyanates. 45, 46 Atopy and smoking Atopy increases the risk of occupational asthma particularly with high molecular weight agents. 1 Atopic laboratory animal workers for example are approximately 13 times more likely than others to develop occupational asthma. 47 There is no increased risk with most low molecular weight agents, 48, 49 but platinum salts and acid anhydrides associated with readily detectible specific IgE antibodies are exceptions. 7, 50 About a third of the population are atopic 2 and the detection of atopy is of no practical value in pre-employment selection. 1, 29 The association with cigarette smoking is complex and not all studies show a consistent effect: there are clearly increased risks with some agents such as platinum salts 7, 16 but smoking might even be protective with others such red cedar asthma. 51 In general, associations have been more readily demonstrated for sensitization using skin prick or radioallergosorbent (RAST) tests than for asthma. 16 
Previous asthma
In Europe, teenagers with asthma are just as likely as others to choose a job where there is a risk of occupational asthma. 52 A previous history of asthma is not significantly associated with occupational asthma 1 and in general is not a reason to deny an asthmatic employment. Pre-existing asthma can make superimposed occupational disease more difficult to detect, however, and there are probably some circumstances where asthmatics should be protected. 53 Previous occupational asthma is a contraindication to employment involving further exposures to the causative agent. Whether or not it should also preclude future work with unrelated asthmagenic agents is unknown but in practice it commonly does. 53 
Workforce surveillance and early detection
There are many settings such as bakeries, laboratory animal houses and some chemical industries where it is accepted that it is not economically or technically practical to reduce exposures to a level that will eliminate occupational asthma. A study of bakeries suggested a safe exposure limit for dust 32 of 0.5 mg/m 3 which was one-tenth of the permitted exposure and one-sixth of bakers' typical exposures. An important aim is therefore to prevent the worst outcomes of occupational asthma by early detection and appropriate management even when the disease cannot be eliminated. In its early stages, occupational asthma is highly dependent on exposures and usually disappears if these cease. After a variable interval the disease becomes self-perpetuating and persists even after the individual is removed from exposure. The duration of symptomatic exposure is an important determinant of outcome 54 and early detection by surveillance of the workforce is a key management strategy. 1 The Ontario isocyanate asthma programme introduced in 1983 was one of the earliest large-scale asthma surveillance programmes. It included preemployment evaluation, 6-monthly respiratory symptom questionnaires and annual spirometry. Those with symptoms or changes in spirometry underwent more detailed medical evaluation. 55 Its introduction was associated with a decrease in the average time taken to diagnose occupational asthma from 3 to 2 years. However, there was a concomitant education programme and tightened exposure controls associated with a 50% reduction in asthma incidence and that might have contributed to the speedier diagnosis. The effectiveness of both this and other surveillance programmes thus remains subject to some doubt despite their widespread use. There is also uncertainty about the optimal interval for surveillance and its necessary duration. Sensitization and occupational asthma are most likely to develop in the first year of exposure 1,56-58 and it seems appropriate for surveillance to be carried out more frequently over that period. Some risk of asthma persists throughout employment and surveillance programmes generally continue indefinitely. 55 
Questionnaires and lung function
Most workplace programmes employ symptom questionnaires and lung function measurements. The overall sensitivity and specificity of these are uncertain and are likely to be dependent on the setting in which they are used. 58 Anxieties about exposures might lead to increased reporting of non-specific respiratory symptoms whereas fears about job security may cause underreporting. 1, 59 Questions about rhinitis may be helpful as occupational rhinitis and asthma frequently occur together, particularly with exposures to high molecular weight agents. 1, 60, 61 The rhinitis usually precedes the asthma, 1, 56, 57 and those with work-related rhinitis are at increased risk of developing asthma, 62 particularly over the subsequent year. 1, 62 The risk is not universal 63 and is not sufficiently well quantified to serve as a basis for excluding an employee from the workplace under most circumstances. 58 It does, however, suggest a need for enhanced surveillance.
Spirometry is widely used in surveillance programmes but it is insensitive in detecting mild asthma 59 and in older populations it will identify chronic obstructive pulmonary disorder (COPD) that might be confused with asthma. Lung function tests have on occasion been shown to be useful when workers are reluctant to report symptoms 64 but in general, spirometry identifies few cases of occupational asthma that would not otherwise be detected by respiratory questionnaires. 1 
Immunological surveillance
In some industries the development of occupational asthma is strongly associated with the presence of specific IgE antibodies. Sensitization precedes the development of asthma and so skin prick and RAST testing can be used within surveillance programmes. 1 These can be sensitive and objective, and they have formed the basis for very effective control programmes. In the platinum refining industry, the identification of a positive skin prick test leads to exclusion from the workplace. 65 In the detergent industry, a positive enzyme skin prick test on annual testing leads to more intensive surveillance and workers are then excluded if they then develop symptoms. 32 A positive test also prompts a review of workplace hygiene and the rate of skin test positivity is used as a measure of overall exposure control. It has been suggested that if the annual sensitization rate can be kept below 3% then occupational asthma could be eliminated in the industry. 29 Surveillance for the development of specific IgE antibodies can thus be used as part of a broader risk management programme. 1 
Diagnosis
Occupational asthma is generally not a straightforward diagnosis. It requires a detailed medical and occupational history, often supplemented by complex investigations. The investigative strategy usually needs to be tailored to individual circumstances and is influenced by the severity of the asthma, the need for medication that might mask airway responses, the willingness of the individual and the employer to cooperate and the ability to analyse and recreate occupational exposures. The diagnosis often has serious implications for the future health and work not only of the individual under investigation but also of fellow workers, and there may be complicating legal issues. Referral to a specialist is usually necessary to allow access to the full range of diagnostic investigations and to allow the history to be interpreted in the light of an understanding of working environments. Those who are investigated and managed by non-specialists are less likely to undergo thorough investigation than those seen in expert centres 66 and may not achieve the appropriate diagnostic standard.
The medical history
The possibility of occupational asthma should be considered in any adult with new onset asthma or with substantial worsening of pre-existing disease. Unfortunately, that does not happen often, [66] [67] [68] and there can be substantial delays in establishing the diagnosis. Santos and colleagues noted that the median time to first physician contact was 3 months in a group of 80 subjects with occupational asthma but the time to diagnosis was 2 years. 69 It is at the early stages when the work-relatedness of symptoms is likely to be greatest, when the need for potentially masking medication is least and when there is the greatest opportunity to influence long-term outcome. Diagnostic tests are usually not practical after the individual has left work and investigations should be carried out as soon as the disease is suspected.
A history of work-related symptoms has a high sensitivity for diagnosing occupational asthma. 1 Important features include a latent interval of asymptomatic exposure and improvements in symptoms after several days away from work. The latter are more easily recognized than deteriorations at work. The specificity of the medical history is poor, however, and without supplementary investigation is likely to lead to an incorrect diagnosis in about one quarter of cases. 4, 70 The symptoms of asthma are non-specific, particularly in the disease's early stages, and a worker's account can be confounded by anxieties about exposures, a suspicious attitude towards the employer, fear of unemployment or the prospect of litigation. Workers often feel better away from work for reasons unrelated to their asthma, 71 and distinguishing the provocation of symptoms by irritant exposures from worsening asthma can be very difficult.
Spirometry and serial peak expiratory flow measurements
Spirometric measurements and reversibility testing can be useful in confirming the diagnosis of asthma. Pre-and post-shift spirometric measurements are sometimes made but they are insensitive and are not recommended for the validation or exclusion of occupational asthma. 1 Serial peak expiratory flow (PEF) measurements obtained at and away from work are useful tools. About two-thirds of patients can make satisfactory recordings 1 but the measurements are technique-dependent and as they are made without direct supervision they can be fabricated, manipulated or subject to psychological influences. 72 They require cooperation and continuing exposures to the environment under suspicion. Measurements should be obtained at least four times per day, as the diagnostic performance of the test falls when fewer are made. 73 There has been no study of the minimum duration of investigation, but 4 weeks or more is generally recommended. 1 A variety of PEF patterns are recognized. Diurnal variation can be less on days away from work, PEF values can fall progressively over sequential days at work and improve gradually at weekends or holidays, or there can be intermittent falls during working weeks with marked improvement after several days away from work. 4 Interpretation may be difficult if exposures at work are intermittent, and the pattern may not allow occupational asthma to be differentiated from work-exacerbated asthma. There is generally good agreement between experts' interpretations 1 and with adequate records their sensitivity and specificity in comparison with specific inhalation challenge tests or expert diagnosis are high. 1 Sensitivity is reported in the range 70-90% and specificity in the range 70-100%. 1, 74, 75 Computer programs such as Oasys-2 can be used to aid the analysis of serial PEF measurements (Figure 2 ). 76 
Airway responsiveness
The measurement of airway responsiveness to methacholine or histamine can be a useful adjunct. The absence of hyperresponsiveness can generally be used to rule out occupational asthma provided the individual is still exposed and is symptomatic. 77 Serial measurements can be used to demonstrate changes in asthma severity in association with occupational exposures. 1, 78 The measurements are made under direct observation and can provide more objective evidence than unobserved serial PEF measurements. Good quality measurements are time-consuming, however, and the technique is reported to have lower sensitivity and specificity compared with serial PEF measurements. 1
Immunological tests
Skin prick and serological tests to identify specific IgE antibodies can be highly sensitive in identifying occupational asthma to most high molecular agents and to a few low molecular weight chemicals such as acid anhydrides, some reactive dyes and platinum salts. 1 Their specificity is poor however, as positive immunological tests can be found in up to 60% of exposed, asymptomatic workers. 57 A positive skin prick test thus only supports a diagnosis of Figure 2 . Serial peak expiratory flow (PEF) measurements in occupational asthma. Serial PEF measurements plotted using Oasys-2 software. 75 Daily maximum, minimum and mean are plotted during periods of exposure and after relocation to an area of minimum exposure. Progressive declines at work and improvements at weekends are shown.
occupational asthma if it is accompanied by appropriate symptoms. Immunological tests are of less value with most low molecular weight agents as specific antibodies are difficult to detect. 79 
Inhalation challenge tests
Specific inhalation challenges in the laboratory come closest to a 'gold-standard' in the diagnosis of occupational asthma. 1 They can be very useful when a satisfactory diagnosis cannot be achieved by other means but they are of limited value in routine clinical practice as they are difficult to administer and interpret. Their use is restricted to a few centres with appropriate expertise. 4 Working environments are often mixed and the appropriate exposure might not be known or might be difficult to recreate in a controlled manner. Realistic challenge techniques that try to recreate the work activity in the laboratory are sometimes used 80 but controlled challenges using closed-circuit exposure equipment are safer. 81 The risk of inducing a severe reaction is a particular concern. 81, 82 Lung function needs to be monitored over 12 hours or more with agents that produce late asthmatic reactions, and challenge protocols often extend over several days with blind or double blind control exposures. 78, 83 The interpretation of the outcome of specific inhalation challenge tests is problematic 84 and a negative inhalation challenge test may not be sufficient to exclude the diagnosis of occupational asthma. 1 Immediate asthmatic reactions beginning within minutes of exposure are relatively easy to detect but they can be triggered by irritant exposures. Late asthmatic reactions begin after 2-4 hours and persist over several hours. They are much more specific to asthma inducers but they are more difficult to distinguish from superimposed circadian variability of lung function particularly if they are of small magnitude. They can be masked by treatment with inhaled corticosteroids or long-acting beta 2 -agonists. Increases in airway responsiveness following an inhalation challenge indicate an asthma inducer but following a single positive laboratory exposure the change might be around the limit of detection of the technique. 85 
Other tests
Eosinophil counts in induced sputum correlate with asthma severity. 86 In those with occupational asthma they fluctuate with workplace exposures 87 and increase after positive inhalation challenge tests. [88] [89] [90] They have been proposed as an adjunct to other tests 90 but they are time-consuming and technically difficult to perform, and the magnitude of clinically significant changes has not been defined. In the laboratory, changes in eosinophil counts can be detected at lower levels of exposure than are needed to change lung function. 91 Exhaled air nitric oxide measurements are related to sputum eosinophil counts 92 and are technically much easier to carry out. They may serve a similar diagnostic function, 88 but there is as yet limited evidence of their usefulness. 4
Management and outcome Health outcomes
Patients with occupational asthma are at risk of progressive worsening of their disease if they continue to be exposed to the causative agent, and affected individuals are generally advised to avoid or at least to substantially reduce any further exposures. 54 The rate of progression can be very variable: some individuals worsen rapidly while others can continue to work for many years and possibly even develop tolerance to the working environment. 54, 93 Anees, for example, identified an average annual forced expiratory volume in 1 second (FEV 1 ) drop of 100 mL in subjects with occupational exposures who continued to work but there was a wide range, with many individuals showing no fall, and others with FEV 1 falls of up to 780 mL. 94 There are, unfortunately, no criteria that can be used to predict in advance the outcome in any individual.
Although the likelihood of improvement is greater in those who have no further exposure to the causative agent, 1 occupational asthma often persists indefinitely even after exposures cease. 1 Reported case series suggest that about 30% of subjects achieve complete resolution of their symptoms but that is probably an underestimate as most studies are from specialist centres that are likely to recruit more severe cases. 54 Factors that favour resolution include relatively normal lung function at the time of diagnosis, and a shorter duration of symptoms before and after diagnosis. 1 Improvement is greatest shortly after the cessation of exposure but can continue for more than 2 years. 95 Although complete avoidance of further exposure in those with occupational asthma is ideal, it is not always practical. Its feasibility often depends on the employer's ability and willingness to redeploy the affected individual, or the practicality of finding alternative work. Redeployment of workers to lower exposure areas is not always effective, 1 as once sensitization occurs the degree of exposure necessary to cause symptoms and perpetuate the disease can be one to two orders of magnitude lower than that needed to cause the sensitization. 46 Issuing respiratory protective equipment has been shown to be effective in some settings but not in others, and it does not usually provide a satisfactory solution. 1
Financial outcomes
Workers with occupational asthma suffer financially, and approximately one-third are unemployed up to 6 years after diagnosis. 1, 96, 97 Most industrialized countries have compensation schemes but these vary considerably both in their diagnostic criteria and in the way they manage affected individuals. Schemes such as those in Quebec and Finland, which incorporate retraining, rehabilitation and salary protection are likely to increase the incentive for individuals to present at an earlier and more manageable stage in their illness. 98 They may therefore be more effective than other schemes 1 : the current unemployment rate for those with occupational asthma in Finland, appears to be little different from the national average. 98 
Pharmacological and other treatments
Occupational asthma responds to treatment with inhaled and oral medications in the same way as non-occupational asthma and when used appropriately these are likely to provide clinical benefit. 1 That is certainly the case once occupational exposures have been controlled but treatment at an earlier stage might hamper the investigation of the asthma by suppressing asthmatic reactions following exposure or reducing PEF variability. Pharmacological treatment does not prevent occupational asthma from deteriorating 99 and, by allowing greater exposure to the agent driving the asthma, might lead to a worse final outcome. Its use during the period of symptomatic exposure needs to be carefully considered.
Immunotherapy is used in other forms of type I hypersensitivity and benefit has been reported with latex, wheat flour and a few other agents. 100 There are anecdotal reports of benefit from anti-IgE antibodies but there has as yet been no detailed study of this. 54, 101 The mainstay of management remains prompt diagnosis and reduction of exposures.
The workplace
A diagnosis of occupational asthma should prompt further investigation of the workplace, as it is likely that other workers are at risk or are already affected. 29 Working practices and exposure control methods should be reviewed and there may be a need for more detailed surveillance of the workforce.
Guidelines and future developments
Evidence-based guidelines are now established as an effective means of translating research findings into health benefits. They are widely used in a variety of medical conditions. 102 The BOHRF guidelines address four key areas with 52 evidence statements and 22 recommendations. They are largely informed by observational studies as many of the important issues in occupational asthma such as aetiology are not readily answered by the randomized controlled trials that attract the highest levels of evidence. However, when observational studies provide consistent and coherent outcomes they can be as valuable as other forms of evidence.
The BOHRF guidelines ( Table 2 ) are complemented by other consensus guidelines and systematic reviews. 4, 103, 104 They have been adopted by the British Thoracic Society (BTS) and supplemented by a comprehensive BTS Standards of Care document 105 that translates the evidence base into clinical practice. These documents are an important step in drawing attention to the problems of occupational asthma, Table 2 . BOHRF guidelines: key recommendations for medical practitioners Ask any adult with new, recurrent or deteriorating asthma about their work and whether their symptoms improve when away from work Always seek objective confirmation if occupational asthma is suspected Investigate with serial peak flow measurements at least four times a day Refer early to a physician with expertise in occupational asthma Manage occupational asthma following established clinical guidelines in conjunction with recommendations about exposure avoidance BOHRF, British Occupational Hygiene Research Foundation.
translating research findings into clinical practice and identifying gaps in our current knowledge.
In the United Kingdom, the Health and Safety Executive (HSE) has set an ambitious target of a 30% reduction in the incidence of occupational asthma from 2001 levels by 2010. There is evidence from previous experience, particularly in Ontario, that this is achievable through a concerted programme of action. Lack of information and awareness is a key contributor to the current unsatisfactory situation and the application of comprehensive management guidelines is an important step towards better control of occupational asthma.
